Nuvation Bio (NUVB) Leases (2023 - 2025)
Nuvation Bio (NUVB) has disclosed Leases for 3 consecutive years, with $3.9 million as the latest value for Q4 2025.
- On a quarterly basis, Leases rose 63.11% to $3.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.9 million, a 63.11% increase, with the full-year FY2025 number at $3.9 million, up 63.11% from a year prior.
- Leases was $3.9 million for Q4 2025 at Nuvation Bio, down from $4.3 million in the prior quarter.
- In the past five years, Leases ranged from a high of $5.3 million in Q1 2025 to a low of $2.4 million in Q4 2024.
- A 3-year average of $3.6 million and a median of $3.6 million in 2023 define the central range for Leases.
- Peak YoY movement for Leases: tumbled 38.71% in 2024, then soared 75.12% in 2025.
- Nuvation Bio's Leases stood at $3.6 million in 2023, then crashed by 33.37% to $2.4 million in 2024, then skyrocketed by 63.11% to $3.9 million in 2025.
- Per Business Quant, the three most recent readings for NUVB's Leases are $3.9 million (Q4 2025), $4.3 million (Q3 2025), and $4.6 million (Q2 2025).